Tandem Diabetes Care: An Earnings Miss Confirms The Bear Case - Downgrade To Sell [Seeking Alpha]
Insulet Corporation (PODD)
Last insulet corporation earnings: 2/25 04:01 pm
Check Earnings Report
US:NASDAQ Investor Relations:
investor.insulet.com/investor-relations
Company Research
Source: Seeking Alpha
Intense competition from Insulet and Medtronic is eroding Tandem's market share, with rivals showing stronger growth and profitability. Management's credibility is under pressure, due to material guidance downgrades and reactive strategy, despite upcoming product catalysts. Caution is warranted, despite low valuation; evidence of stabilization is needed before reconsidering a more positive stance. mesh cube Introduction Tandem Diabetes Care NASDAQ: TNDM ) stock is reeling following its release of second quarter 2025 earnings The report came a couple of months after my last analysis in TNDM. I have largely advocated for caution on the stock, maintaining a Hold rating This article was written by Analyst's Disclosure: I/we have no stock, option or similar derivative position in any of the companies mentioned, and no plans to initiate any such positions within the next 72 hours. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation
Show less
Read more
Impact Snapshot
Event Time:
PODD
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
PODD alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
PODD alerts
High impacting Insulet Corporation news events
Weekly update
A roundup of the hottest topics
PODD
News
- Truist Cuts Insulet (PODD) PT but Maintains Buy as Top MedTech Pick for 2026 [Yahoo! Finance]Yahoo! Finance
- Should Insulet's (PODD) Expanded Pod Recycling Effort Reframe Its Long-Term Sustainability Edge? [Yahoo! Finance]Yahoo! Finance
- Insulet (NASDAQ:PODD) had its "buy" rating reaffirmed by analysts at UBS Group AG.MarketBeat
- Insulet (NASDAQ:PODD) had its price target lowered by analysts at Truist Financial Corporation from $412.00 to $390.00. They now have a "buy" rating on the stock.MarketBeat
- Insulet (NASDAQ:PODD) was upgraded by analysts at Evercore ISI to a "strong-buy" rating.MarketBeat
PODD
Earnings
- 11/6/25 - Beat
PODD
Sec Filings
- 12/19/25 - Form 8-K
- 12/17/25 - Form 8-K
- 12/16/25 - Form 4
- PODD's page on the SEC website